Cardinal Health said fourth-quarter 2025 revenue was $60.2 billion, relatively flat to the prior-year quarter, and increased 21% excluding the impact of a previously communicated contract expiration. Non-GAAP operating earnings increased 19% to $719 million, and GAAP operating earnings were $428 million.

1. 01

   Cardinal Health said fourth-quarter 2025 revenue was $60.2 billion, relatively flat to the prior-year quarter, and increased 21% excluding the impact of a previously communicated contract expiration. Non-GAAP operating earnings increased 19% to $719 million, and GAAP operating earnings were $428 million.

2. 02

   The company said full-year 2025 revenue was $222.6 billion, a 2% decrease from the prior year, and non-GAAP diluted EPS increased 9% to $8.24. Full-year adjusted free cash flow was $2.5 billion.

3. 03

   Cardinal Health raised its fiscal 2026 non-GAAP diluted EPS guidance to $9.30 to $9.50 from the prior outlook of $9.10 to $9.30. It provided adjusted free cash flow guidance of $2.75 billion to $3.25 billion.

4. 04

   The company said its multi-specialty management services organization, The Specialty Alliance, entered into a definitive agreement to acquire Solaris Health, the country's leading urology MSO with over 750 providers.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.